{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T23:40:29Z","timestamp":1687390829676},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.humimm.2012.03.009","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T22:58:41Z","timestamp":1334271521000},"page":"612-619","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of a non-viral vaccine in smallpox-vaccinated individuals and immunized HLA-transgenic mice"],"prefix":"10.1016","volume":"73","author":[{"given":"Alice P.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boby","family":"Makabi-Panzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David V.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2012.03.009_b0005","first-page":"213","article-title":"Eradication and cessation of programmes","volume":"62","author":"Minor","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.humimm.2012.03.009_b0010","doi-asserted-by":"crossref","unstructured":"Anonymous. CDC MMWR 2003;52:537\u201340.","DOI":"10.1099\/jmm.0.05093-0"},{"key":"10.1016\/j.humimm.2012.03.009_b0015","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increases in monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoan","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humimm.2012.03.009_b0020","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.humimm.2012.03.009_b0025","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1086\/520936","article-title":"Antibodies to the A27L protein of vaccinia virus neutralize and protect against infection, but represent a minor component of Dryvax vaccine-induced immunity","volume":"196","author":"He","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.humimm.2012.03.009_b0030","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.humimm.2012.03.009_b0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S0022172400028679","article-title":"Inactivated smallpox vaccine. A comparison of inactivation methods","volume":"68","author":"Turner","year":"1970","journal-title":"J Hyg Camb"},{"key":"10.1016\/j.humimm.2012.03.009_b0040","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.4049\/jimmunol.164.6.3246","article-title":"A poxvirus protein that binds to and inactivates IL18, and inhibits NK cell response","volume":"164","author":"Born","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0045","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1099\/0022-1317-83-11-2833","article-title":"The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model","volume":"83","author":"Symons","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.humimm.2012.03.009_b0050","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","article-title":"A rational strategy to design multi-epitope immunogens based on multiple Th lymphocyte epitopes","volume":"168","author":"Livingston","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0055","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.4049\/jimmunol.169.10.5827","article-title":"A unique mechanism for innate cytokine promotion of T cell responses to viral infections","volume":"169","author":"Pien","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0060","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.4049\/jimmunol.147.9.3149","article-title":"IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis","volume":"147","author":"Scott","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0065","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1073\/pnas.96.20.11537","article-title":"IL-18 binding and inhibition of interferon \u03b3 induction by human poxvirus-encoded proteins","volume":"96","author":"Xiang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humimm.2012.03.009_b0070","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20071854","article-title":"The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination","volume":"205","author":"Xu","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2012.03.009_b0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","article-title":"Scheme for ranking potential HLA-A2 binding peptide-based on independent binding of individual peptide side-chains","volume":"152","author":"Parker","year":"1994","journal-title":"J Immunol"},{"issue":"Database issue","key":"10.1016\/j.humimm.2012.03.009_b0080","doi-asserted-by":"crossref","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","article-title":"The immune epitope database 2.0","volume":"38","author":"Vita","year":"2010","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.humimm.2012.03.009_b0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.humimm.2012.03.009_b0090","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1084\/jem.20031598","article-title":"HIV-1 viremia prevents the establishment of Interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity","volume":"198","author":"Younes","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2012.03.009_b0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/JVI.72.1.170-179.1998","article-title":"The 131-amino-acid repeat region of the essential 39-kilodalton core protein of fowlpox virus FP9, equivalent to vaccinia virus A4L protein, is nonessential and highly immunogenic","volume":"72","author":"Boulanger","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2012.03.009_b0100","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate","volume":"72","author":"Chung","year":"1998","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.humimm.2012.03.009_b0105","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.humimm.2008.09.009","article-title":"Vaccinia virus-specific CD8+ T cell responses target a group of epitopes without a strong immunodominance hierarchy in humans","volume":"69","author":"Terajima","year":"2008","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0110","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates adsorption of intracellular mature virions to cells","volume":"73","author":"Hsaio","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2012.03.009_b0115","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0264-410X(98)00018-8","article-title":"Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein","volume":"16","author":"Makabi-Panzu","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.humimm.2012.03.009_b0120","first-page":"191","article-title":"HLA-DQ molecular heterogeneity in HLA-DR4-Dw4 consanguineous cell lines","volume":"4","author":"Fernandez","year":"1986","journal-title":"Dis Mark"},{"key":"10.1016\/j.humimm.2012.03.009_b0125","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1158\/1078-0432.CCR-03-0340","article-title":"Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy","volume":"10","author":"Cardillo","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humimm.2012.03.009_b0130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/eji.1830230603","article-title":"Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes","volume":"23","author":"Nijman","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0135","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.humimm.2012.03.009_b0140","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0198-8859(01)00298-1","article-title":"Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations","volume":"62","author":"Cao","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0145","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.tp.0000258588.09356.d7","article-title":"Improved definition of human leukocyte antigen frequencies among minorities and applicability to estimates of transplant compatibility","volume":"83","author":"Lefell","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2012.03.009_b0150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.humimm.2010.10.017","article-title":"Human leukocyte antigens-A, -B, -C, DRB1 and haplotype frequencies in Americans originating from Southern Europe: contrasting patterns of population differentiation between Italian and Spanish Americans","volume":"72","author":"Mack","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0155","doi-asserted-by":"crossref","first-page":"e4089","DOI":"10.1371\/journal.pone.0004089","article-title":"Concurrent generation of effector and central memory CD8 T cells during vaccinia virus infection","volume":"3","author":"Laouar","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2012.03.009_b0160","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1073\/pnas.0502393102","article-title":"HIV-1-specific IFN-\u03b3\/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells","volume":"102","author":"Zimmerli","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humimm.2012.03.009_b0165","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia infection of mice","volume":"172","author":"Xu","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0170","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","article-title":"Distinct time effects of vaccination on long-term proliferative and IFN-\u03b3-producing T cell memory to smallpox in humans","volume":"199","author":"Combadiere","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2012.03.009_b0175","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00040-09","article-title":"Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model","volume":"16","author":"Meseda","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0180","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: a longitudinal study","volume":"121","author":"Taub","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.humimm.2012.03.009_b0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0042-6822(92)90304-8","article-title":"Fine specificity of the B-cell epitopes recognized in HIV-1 NEF by human sera","volume":"187","author":"Tahtinen","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.humimm.2012.03.009_b0190","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1128\/JVI.71.7.5473-5480.1997","article-title":"Immunogenicity of a contiguous T-B synthetic epitope of the A\/PR\/8\/34 influenza virus","volume":"71","author":"Brumeanu","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2012.03.009_b0195","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1128\/JVI.65.9.4681-4690.1991","article-title":"Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16","volume":"65","author":"Comerford","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2012.03.009_b0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0006-291X(90)90402-9","article-title":"Relative positioning of the T cell and B cell determinants on an immunogenic peptide: its influence on antibody production","volume":"169","author":"Hachimura","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.humimm.2012.03.009_b0205","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2567.1996.d01-673.x","article-title":"Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology","volume":"88","author":"Harris","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2012.03.009_b0210","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.174.1.557","article-title":"Human autoantibodies modulate the T cell epitope repertoire but fail to unmask a pathogenic cryptic epitope","volume":"174","author":"Quaratino","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2012.03.009_b0215","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1128\/JVI.66.6.3385-3390.1992","article-title":"Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes","volume":"66","author":"Roehrig","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2012.03.009_b0220","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1084\/jem.181.6.1957","article-title":"Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants","volume":"181","author":"Simitsek","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2012.03.009_b0225","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/422999","article-title":"Clinical efficacy of intramuscular vaccinia immune globulin: a literature review","volume":"39","author":"Hopkins","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885912000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885912000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T23:25:54Z","timestamp":1687389954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885912000778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0198885912000778"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2012.03.009","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}